Market Timing with TurnerTrends Provides Great Stock Picks for the Sophisticated Investor   Timing the Market well requires Stock Picks that work

TurnerTrends Stock Rating Report for GENT

Ticker: 
Data valid for week beginning September 06, 2010

Ticker Company Name
GENT   [News] Gentium SpA (ADR)
Company Profile
"Gentium S.p.A. is a biopharmaceutical company focused on the development and manufacture of defibrotide, a drug based on single-stranded deoxyribonucleic acid (DNA) derived from pig intestines. The Company’s development of defibrotide has been focused on the treatment and prevention of a disease called hepatic veno-occlusive disease (VOD), a condition, in which some of the veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation treatments, that are given prior to stem cell transplantation. The Company has completed two clinical trials, a Phase III trial of defibrotide for the treatment of severe VOD in the United States, Canada and Israel and a Phase II-III pediatric trial in Europe for the prevention of VOD. Defibrotide has been given orphan status by the United States Food and Drug Agency (FDA), and the European Medicines Agency (EMEA). The Company also manufactures defibrotide and sulglicotide at its manufacturing facility near Como, Italy."

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
Technical Chart (3 year) Sector Chart Industry Chart

GENT Technical Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for GENT. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Gentium SpA (ADR) next week. Sign up today and start making money!

FREE TRIAL!!


Stock Information
Friday's Close $5.14
Volume Avg. 23026 shares
Industry Biotechnology and Drugs
Sector Healthcare
Our Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

Stock Financials
Profit Margin .00%
Operating Margin -10.93%
Debt-to-Equity .48%
P/E ttm 0.00
EPS ttm $-0.140
Total Revenue $18,230,000
Market Cap $76,880
Annual Dividend $.00
Yield .000%
ROE 0.40%
Revenue Growth Rate Quarterly 391.80%
Earnings Growth Rate Quarterly 98.90%
Earnings Growth Rate Yearly 0.00%
Multi-Year Average Revenue Growth Rate 22.43%
Multi-Year Average Earnings Growth Rate N/A
Institutional Ownership Members Only
Value Rating Members Only
TurnerTrends Score  (Range: 0 to 200) Members Only


Latest News

Thu, 12 Aug 2010 11:07:25 GMTH1 2010 GENTIUM S P A Earnings Release - Time Not Supplied
Thu, 12 Aug 2010 11:00:00 GMTGentium Reports First Half 2010 Financial Results
Mon, 09 Aug 2010 20:42:00 GMTGentium to Review First Half 2010 Financial Results
Fri, 09 Apr 2010 17:04:23 GMTGENTIUM S.P.A. Financials
Mon, 05 Apr 2010 13:15:00 GMTSkymark Research Initiates Independent Research Coverage on Gentium S.p.A.
Thu, 01 Apr 2010 14:22:27 GMTAir Transport Services, Borders: Early Volume Movers
Wed, 24 Mar 2010 13:35:24 GMTPoniard, Xfone: Early Volume Plays
Mon, 22 Mar 2010 10:50:00 GMTBiotech Stock Alert for Gentium SpA Issued by InvestorSoup
News provided by Yahoo! Finance
Home | Stock Ratings | Top 100 Stocks | New Hot Stock Picks | Sector Analyzer | Industry Analyzer | Member's Area | Articles | FAQ | Contact Us | Terms of Use | Advertise
(C) Copyright TurnerTrends, Inc.  All Rights Reserved.

*Past performance does not guarantee future results. TurnerTrends makes no representations or warrants that just because a stock would have made a profit in the past, using TurnerTrends buy recommendations or sell recommendations, it will make any profits in the future. It is possible that these same stocks will lose money in the future using the TurnerTrends stock recommendations.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither TurnerTrends nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the TurnerTrends site, a user agrees not to redistribute the information found therein.

thinkorswim, Division of TD AMERITRADE, Inc. and TurnerTrends are separate, unaffiliated companies and are not responsible for each other's services and products.